Skip to main content
. Author manuscript; available in PMC: 2021 Aug 10.
Published in final edited form as: Cancer Cytopathol. 2019 Mar 12;127(3):192–201. doi: 10.1002/cncy.22110

Table 2:

Results of p53 immunostaining and sequencing analysis

Case ID p53 STAINING PATTERNa TP53 MUTATION (ALLELIC FREQUENCY)b
Brush Cyto Tissue Brush Cyto Tissue
1 wt wt No Mutation -
2 wt wt No Mutation No Mutation
wt wt No Mutation -
3 wt wt - -
4 wt wt No Mutation No Mutation
wt wt No Mutation No Mutation
5 wt wt - -
wt wt - -
6 wt wt - -
7 wt wt - -
8 wt wt - -
9 Focal MutD Focal MutD No Mutation No Mutation
10 wt wt No Mutation -
11 MutD MutD p.R175H (0.81) p.R175H (0.45)
12 MutN MutN c.559+1G>T, p.? (0.11)c c.559+1G>T, p.? (0.25)e
wt wt No Mutation No Mutation
13 MutD MutD p.D281N (0.32) p.D281N (0.44)
MutD MutD p.D281N (0.17) p.D281N (0.16)
14 wt wt - -
15 MutN MutN p.E271* (0.34) p.E271* (0.56)
a.

Staining pattern is reported for the lesion, if present; otherwise, refers to background normal epithelial cells. Patterns of p53 immunoreactivity: wt – wildype, MutD – Mutated, diffuse nuclear pattern, MutN – Mutated, null pattern.

b.

Only non-synonymous variants shown.‘ – ’ indicates sequencing was not performed.

c.

This mutation has been reported to affect splicing, resulting in loss of gene expression.